24 studies found for:    Open Studies | "Cholangitis"
Show Display Options
Rank Status Study
1 Recruiting Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis
Intervention: Drug: ursodeoxycholic acid (UDCA) withdrawal and reinstitution
2 Recruiting Endoscopic Ultrasound as an Early Diagnostic Tool for Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis
Intervention:
3 Recruiting Erlotinib for Chemoprevention in Trisomy 7 Positive Primary Sclerosing Cholangitis (PSC)
Conditions: Primary Sclerosing Cholangitis;   Trisomy 7;   Cholangiocarcinoma;   Chemoprevention
Intervention: Drug: Erlotinib (Tarceva)
4 Recruiting Combination Therapy With Ursodeoxycholic Acid (UDCA) and All-Trans Retinoic Acid (ATRA) for Treatment of Primary Sclerosing Cholangitis
Condition: Cholangitis, Sclerosing
Intervention: Drug: Oral all-trans retinoic acid (ATRA)
5 Recruiting Mitomycin C Therapy for Patients With Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis
Interventions: Drug: Mitomycin C;   Drug: Normal saline
6 Recruiting Short-term Stenting Versus Balloon Dilatation for Dominant Strictures in Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis
Interventions: Procedure: plastic endoprosthesis;   Procedure: balloon dilatation
7 Recruiting Norursodeoxycholic Acid in the Treatment of Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis
Interventions: Drug: norUDCA;   Drug: Placebo
8 Unknown  Probiotics in Patients With Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis
Intervention: Drug: Probiotics
9 Recruiting Primary Sclerosing Cholangitis With Oral Vancomycin by the Study of Its Antimicrobial and Immunomodulating Effects
Condition: Primary Sclerosing Cholangitis
Intervention: Drug: Oral Vancomycin
10 Recruiting GS-6624 in the Prevention of Progression of Liver Fibrosis in Subjects With With Primary Sclerosing Cholangitis (PSC)
Condition: Primary Sclerosing Cholangitis (PSC)
Interventions: Biological: GS-6624;   Biological: Placebo
11 Unknown  NPD Measurements in PSC Patients
Condition: Primary Sclerosing Cholangitis
Intervention:
12 Recruiting Genomics of Primary Sclerosing Cholangitis (PSC)
Condition: Primary Sclerosing Cholangitis (PSC)
Intervention: Genetic: Genetic Analysis
13 Recruiting A Pilot Study of Xifaxan to Treat Patients With PSC
Condition: Primary Sclerosing Cholangitis (PSC)
Intervention: Drug: Xifaxan
14 Recruiting Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
Conditions: Inflammatory Bowel Disease (IBD);   Primary Sclerosing Cholangitis (PSC);   Colorectal Neoplasms;   Colorectal Cancer
Intervention:
15 Recruiting Liver Transplantation for Hilar Cholangiocarcinoma in Association With Neoadjuvant Radio- and Chemo-therapy
Conditions: Hilar Cholangiocarcinoma;   Primary Sclerosing Cholangitis
Interventions: Procedure: Liver transplantation;   Radiation: 45 Gy external radiations;   Radiation: Endoluminal bile duct Brachytherapy;   Drug: Capecitabine;   Procedure: Pre liver transplantation laparoscopic hand assisted staging
16 Unknown  Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis
Conditions: Hepatitis C;   Hepatitis B;   Autoimmune Hepatitis;   Liver Cirrhosis, Biliary;   Cholangitis, Sclerosing
Intervention:
17 Unknown  The Patency Period of the New Plastic Anti-reflux Biliary Stent
Conditions: Pancreatitis;   Cholangitis
Interventions: Device: Anti-reflux Tannenbaum biliary stent;   Device: Ordinary Tannenbaum biliary stent
18 Recruiting Biliary Candidiasis - Optimization of Diagnostics and Therapy
Conditions: Secondary Cholangitis;   Bile Duct Strictures of Unknown Origin
Intervention: Procedure: ERCP
19 Not yet recruiting Transient ECG Changes in Patients With Acute Biliary Disease
Conditions: Acute Cholecystitis;   Biliary Colic;   Acute Cholangitis
Intervention:
20 Unknown  Use of Probiotics to Prevent Cholangitis in Children With Biliary Atresia After the Kasai Portoenterostomy
Condition: Biliary Atresia
Intervention: Drug: Lactobacillus casei rhamnosus (Lcr35)

Previous Page Studies Shown (1-20) Next Page (21-24) Show next page of results
Indicates status has not been verified in more than two years